Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01780324 · ClinicalTrials.gov registry record · NA
Lidocaine Analgesia for Urethral Catheterization in Children
A NA study of Pediatric Presentation of Urinary Tract Infection, sponsored by Seattle Children's Hospital.
- Completed
- Registry status
- NA
- Development phase
- 80
- Enrollment target
- 1
- Study location
NCT01780324 is a NA study of Pediatric Presentation of Urinary Tract Infection that has completed, run by Seattle Children's Hospital. The registered enrollment target is 80 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01780324, a NA study of Pediatric Presentation of Urinary Tract Infection, has completed, sponsored by Seattle Children's Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
Primary Aim 1\. To measure difference in pain via Faces, Legs, Activity, Cry and Consolability (FLACC) Pain Scale score at the time of transurethral bladder catheterization for urine collection in children who do and do not receive intraurethral 2% lidocaine jelly prior to catheterization. Secondary Aims 1. To assess gender differences in pain control during transurethral bladder catheterization with and without pain control using intraurethral 2% lidocaine jelly. 2. To assess patient discomfort with administration of intraurethral 2% lidocaine jelly. To assess parental impression of discomfort between intervention and control groups. 3. To assess pain associated with the administration of intraurethral 2% lidocaine jelly. 4. To measure difference in pain via Modified Behavioral Pain Scale (MBPS) score at the time of TUBC for urine collection in children who do and do not receive intraurethral 2% lidocaine jelly prior to catheterization.
Conditions Studied
Interventions
- DRUG Lidocaine
Study Locations (1)
Washington
- Seattle Children's Hospital - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2013-01 |
| Est. Completion | 2015-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01780324
The ClinicalTrials.gov registry entry for NCT01780324 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Seattle Children's Hospital, which has 168 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Pediatric Presentation of Urinary Tract Infection appearing as the primary indexed condition, and to 1 intervention - of which Lidocaine is the first listed.
NCT01780324 reports 1 study location spanning 1 distinct geographic area - top geographies include Washington.
Frequently Asked Questions
What is clinical trial NCT01780324 about?
NCT01780324 is a clinical study titled "Lidocaine Analgesia for Urethral Catheterization in Children". Primary Aim 1\. To measure difference in pain via Faces, Legs, Activity, Cry and Consolability (FLACC) Pain Scale score at the time of transurethral bladder catheterization for urine collection in children who do and do not receive intraurethral 2% lidocaine jelly prior to catheterization. Seconda...
What is the current status of trial NCT01780324?
This trial is currently completed. It is a NA study. The enrollment target is 80 participants. The study started on 2013-01. Estimated completion is 2015-05.
What conditions does trial NCT01780324 study?
This clinical trial studies the following conditions: Pediatric Presentation of Urinary Tract Infection.
What interventions are being tested in trial NCT01780324?
The interventions under investigation include: Lidocaine (DRUG).
Who is sponsoring clinical trial NCT01780324?
This trial is sponsored by Seattle Children's Hospital, which has 168 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01780324 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.